3,142 reports of this reaction
1.2% of all Repatha reports
#19 most reported adverse reaction
INFLUENZA LIKE ILLNESS is the #19 most commonly reported adverse reaction for Repatha, manufactured by Amgen USA Inc.. There are 3,142 FDA adverse event reports linking Repatha to INFLUENZA LIKE ILLNESS. This represents approximately 1.2% of all 269,908 adverse event reports for this drug.
Patients taking Repatha who experience influenza like illness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INFLUENZA LIKE ILLNESS is a less commonly reported adverse event for Repatha, but still significant enough to appear in the safety profile.
In addition to influenza like illness, the following adverse reactions have been reported for Repatha:
The following drugs have also been linked to influenza like illness in FDA adverse event reports:
INFLUENZA LIKE ILLNESS has been reported as an adverse event in 3,142 FDA reports for Repatha. This does not prove causation, but indicates an association observed in post-market surveillance data.
INFLUENZA LIKE ILLNESS accounts for approximately 1.2% of all adverse event reports for Repatha, making it a notable side effect.
If you experience influenza like illness while taking Repatha, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.